Índice

• • ·Editorial Board

    Página :i

    
• • ·Contents

    Página :iii

    

• Updates in Neurogenetics

  • ·Updates in neurogenetics

    Página :355-356

    A. Durr, C. Verny

    Esquema Esquema
  • ·A developmental component to Huntington's disease

    Página :357-362

    L. Ratié, S. Humbert

    Resumen Resumen Esquema Esquema  
  • ·Epileptic encephalopathies and progressive neurodegeneration

    Página :363-367

    R. Guerrini, V. Conti

    Resumen Resumen Esquema Esquema  
  • ·Lessons from genetic studies in Alzheimer disease

    Página :368-377

    G. Nicolas

    Resumen Resumen Esquema Esquema  
  • ·Gene editing as a therapeutic strategy for spinocerebellar ataxia type-3

    Página :378-382

    N. Déglon

    Resumen Resumen Esquema Esquema  
  • ·Identification and characterization of repeat expansions in neurological disorders: Methodologies, tools, and strategies

    Página :383-392

    E. Leitão, C. Schröder, C. Depienne

    Resumen Resumen Esquema Esquema  
  • ·RFC1: Motifs and phenotypes

    Página :393-409

    V. Delforge, C. Tard, J.-B. Davion, K. Dujardin, A. Wissocq, C.-M. Dhaenens, E. Mutez, V. Huin

    Resumen Resumen Esquema Esquema   
  • ·Spinocerebellar ataxia 27B (SCA27B), a frequent late-onset cerebellar ataxia

    Página :410-416

    G. Clément, S. Puisieux, D. Pellerin, B. Brais, C. Bonnet, M. Renaud

    Resumen Resumen Esquema Esquema  
  • ·C9ORF72 hexanucleotide repeat expansion: From ALS and FTD to a broader pathogenic role?

    Página :417-428

    C. Sellier, P. Corcia, P. Vourc’h, L. Dupuis

    Resumen Resumen Esquema Esquema  

• Original articles

  • ·Prevalence of multiple sclerosis in France in 2021: Data from the French health insurance database

    Página :429-437

    C. Pierret, M. Mainguy, E. Leray

    Resumen Resumen Esquema Esquema   
  • ·Prevalence of multiple system atrophy: A literature review

    Página :438-450

    S. Kaplan

    Resumen Resumen Esquema Esquema   
  • ·Epidemiology of myasthenia gravis in France: Incidence, prevalence, and comorbidities based on national healthcare insurance claims data

    Página :451-458

    S. Keovilayhong, A. Mulliez, L. Feral, C. Chenaf, P. Clavelou, X. Moisset, F. Taithe, L. Poncet Megemont

    Resumen Resumen Esquema Esquema   

• Letters to the editor

  • ·Guillain-Barré syndrome following subthalamic nucleus – Deep Brain Stimulation in Parkinson's disease: A case report

    Página :459-461

    J. Theuriet, C. Aguesse, F. Bouhour, L. Jomir, S. Thobois, S. Prange

    Esquema Esquema
  • ·Vanishing white matter in multiple mitochondrial dysfunction syndrome-2 due to compound heterozygosity for novel BOLA3 variants

    Página :461-463

    J. Finsterer

    Esquema Esquema  
  • ·Directional deep brain stimulation is useful to correct the misplacement of intracerebral electrode after reimplantation

    Página :463-465

    G. Costentin, S. Derrey, D. Maltête

    Esquema Esquema  
  • ·Stroke-like manifestations of angioedema: A case report and the identification of a novel mutation

    Página :465-467

    J.-D. Karam, X. Boulu, G. Hardy, Y. Buron

    Esquema Esquema  
  • ·Neurological disorders related to recreational nitrous oxide abuse: Two sides of the same coin

    Página :467-469

    R. Delsanti, C. Arnaud, G. Defer

    Esquema Esquema  
  • ·Sensorimotor deficit: To worm information out of white blood cell count!

    Página :469-470

    M. Camard, C. Labeyrie, S. Bessis, G. Beaudonnet, D. Beauvais

    Esquema Esquema
  • ·Antibody responses to SARS-CoV-2 vaccines in neuromuscular disorders may depend on their etiology and current drug treatment

    Página :470-471

    J. Finsterer

    Esquema Esquema